Eficácia do ILIB-Modificado sobre os parâmetros clínicos periodontais e controle glicêmico em pacientes com Periodontite portadores de Diabetes Tipo II
Periodontitis and type II diabetes are chronic and worldwide high prevalent conditions with a bidirectional relationship between them. Due to this relationship, the proposition of auxiliary therapies for the treatment of periodontitis in diabetic patients, including the low-intensity laser, is a...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | Dissertação |
| Idioma: | pt_BR |
| Publicado em: |
Brasil
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/jspui/handle/123456789/28461 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | Periodontitis and type II diabetes are chronic and worldwide high prevalent conditions
with a bidirectional relationship between them. Due to this relationship, the proposition
of auxiliary therapies for the treatment of periodontitis in diabetic patients, including the
low-intensity laser, is a reality. The low-intensity laser is attached to a bracelet over the
radial artery to radiate the blood cells through the technique called modified ILIB
(Intravascular Laser Irradiation of Blood), aiming the control of the plasma glucose and
chronic inflammatory processes. Therefore, this research evaluated the efficacy of the
modified ILIB in improving clinical periodontal parameters, such as HbA1c and fasting
blood glucose of patients with periodontitis and type II diabetes on a randomized,
double-blinded, longitudinal clinical study. The sample included 21 patients distributed
in two groups. The control group (CG) received conventional periodontal treatment
(scaling and root planning, and oral hygiene guidance), and the test group (TG) received
conventional periodontal treatment and 10 laser applications through the modified ILIB
technique. The PI and GBI hygiene indexes, the clinical periodontal
parameters BoP, PD, CAL, the fasting blood glucose levels and HbA1c were evaluated
at the baseline and after 4 months (T4) of treatment for both groups. There were no
differences at the intergroup and intragroup comparisons (p>0.05) for the analysis of
Hb1AC blood parameters and fasting blood glucose. Concerning to the periodontal
parameters, the intragroup analysis showed a significant decay (p<0.05) for the PI,
BoP, PD, and CAL indexes between the baseline and T4, however, the intergroup
analysis showed no differences between CG and TG (p>0.05) for all the indexes
compared. Thus, based on the results is possible to state that the modified ILIB do not
improved the glycemic control and the periodontal treatment on type II diabetes
patients. |
|---|